BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/18/2023 1:21:51 PM | Browse: 495 | Download: 1867
Publication Name World Journal of Psychiatry
Manuscript ID 84995
Country China
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Retrospective Study
Article Title Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
Manuscript Source Unsolicited Manuscript
All Author List Jin-Ling Liu, Zhi-Mei Tan and Shu-Jie Jiao
ORCID
Author(s) ORCID Number
Shu-Jie Jiao http://orcid.org/0009-0007-2395-2425
Funding Agency and Grant Number
Corresponding Author Shu-Jie Jiao, PhD, Doctor, Doctor, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou 450000, Henan Province, China. jsj331253@126.com
Key Words Repetitive transcranial magnetic stimulation; Olanzapine; Amisulpride; Treatment-refractory schizophrenia; Therapeutic effectiveness; Cognitive function
Core Tip Patients with treatment-refractory schizophrenia (TRS) always have unsatisfactory treatment response and prognosis despite antipsychotic therapy, which poses significant challenges to clinical management. Therefore, it is necessary to continuously explore and validate effective treatments for TRS.
Publish Date 2023-07-18 13:21
Citation Liu JL, Tan ZM, Jiao SJ. Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia. World J Psychiatry 2023; 13(7): 453-460
URL https://www.wjgnet.com/2220-3206/full/v13/i7/453.htm
DOI https://dx.doi.org/10.5498/wjp.v13.i7.453
Full Article (PDF) WJP-13-453-with-cover.pdf
Full Article (Word) WJP-13-453.docx